— Know what they know.
Not Investment Advice
Also trades as: 0HVB.L (LSE) · $vol 1M

CNC NYSE

Centene Corp.
1W: -3.0% 1M: +9.8% 3M: +11.1% YTD: +64.4% 1Y: +101.6% 3Y: -4.5% 5Y: +6.1%
$68.67
+0.64 (+0.94%)
 
Weekly Expected Move ±3.7%
$65 $68 $70 $73 $75
NYSE · Healthcare · Medical - Healthcare Plans · Tech Score Buy · Power 70 · $33.9B mcap · 485M float · 0.958% daily turnover · Short 41% of daily vol
Credit Risk of going bust: higher than 60% of companies Debt: 31.4% of company value Bonds: $1.05B held by 553 funds, 128 bp over Treasuries → details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $2.72 (down 96%), Centene Corp. would be worth roughly what it owes.
Total debt $15.54B against a stock market value of $33.92B.
Distance to default 4.22 (Merton model): prices to 2026-10-27, balance sheet 2026-09-30, debt counted $7.82B (short-term plus half of long-term), stock volatility 47.3%; Altman Z'' 1.62. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
50.6 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 6.4%  ·  5Y Avg: 0.2%
Cost Advantage
52
Intangibles
35
Switching Cost
52
Network Effect
55
Scale ★
68
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. CNC shows a Weak competitive edge (50.6/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Efficient Scale. ROIC of 6.4% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$76
Avg Target
$76
High
Based on 39 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 27Hold: 16Sell: 1Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$75.57
Analysts7
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-08-18 UBS — $61 $79 +18 +22.6% $64.43
2026-08-11 Argus Research John Staszak Initiated $80 — +20.2% $66.56
2026-08-03 Bernstein — $59 $79 +20 +26.7% $62.37
2026-08-03 Stifel Nicolaus — Initiated $79 — +27.0% $62.22
2026-07-29 Morgan Stanley Erin Wright $57 $66 +9 +6.0% $62.27
2026-07-29 Robert W. Baird — $69 $66 -3 +3.1% $64.02
2026-07-29 Barclays Andrew Mok $75 $80 +5 +25.0% $64.02
2026-07-14 Truist Financial David MacDonald $71 $78 +7 +14.2% $68.29
2026-07-13 Wells Fargo — $44 $69 +25 +2.4% $67.35
2026-07-07 Raymond James Sarah James $60 $75 +15 +13.6% $66.05
2026-06-23 RBC Capital Ben Hendrix Initiated $70 — +9.9% $63.67
2026-06-08 Mizuho Securities — $58 $63 +5 +1.1% $62.33
2026-06-04 Morgan Stanley Erin Wright $38 $57 +19 -4.3% $59.55
2026-06-01 Truist Financial — $58 $71 +13 +19.2% $59.59
2026-05-26 Barclays — $63 $75 +12 +30.1% $57.65
2026-05-22 UBS — $42 $61 +19 +5.6% $57.77
2026-05-20 Mizuho Securities Ann Hynes $41 $58 +17 -1.9% $59.15
2026-05-20 Deutsche Bank — $39 $80 +41 +35.2% $59.15
2026-04-29 Truist Financial — $49 $58 +9 +10.1% $52.69
2026-04-29 Oppenheimer — $45 $58 +13 +17.0% $49.57
2026-04-29 Goldman Sachs Scott Fidel $38 $40 +2 -19.3% $49.57
2026-04-29 Barclays — $54 $63 +9 +27.1% $49.57
2026-04-29 Raymond James Sarah James Initiated $60 — +21.0% $49.57
2026-04-28 Cantor Fitzgerald — Initiated $60 — +21.0% $49.57
2026-04-20 Jefferies David Windley $72 $39 -33 +2.2% $38.16
2026-03-10 Mizuho Securities Ann Hynes $47 $41 -6 +12.6% $36.40
2026-02-25 Truist Financial — $45 $49 +4 +14.2% $42.90
2026-02-18 Wells Fargo Stephen Baxter $43 $44 +1 +6.7% $41.23
2026-02-10 Deutsche Bank — $91 $39 -52 -1.8% $39.72
2026-01-09 Mizuho Securities — $40 $47 +7 +0.2% $46.92
2026-01-07 Wells Fargo — $41 $43 +2 -6.0% $45.74
2026-01-06 Bernstein — $45 $59 +14 +30.2% $45.30
2026-01-05 Barclays — $44 $54 +10 +29.2% $41.78
2025-11-20 Bernstein — $36 $45 +9 +29.2% $34.83
2025-11-04 Barclays Andrew Mok $33 $44 +11 +27.5% $34.50
2025-10-30 Truist Financial — $42 $45 +3 +26.4% $35.62
2025-10-30 UBS — $45 $42 -3 +16.3% $36.12
2025-10-30 Oppenheimer Michael Wiederhorn $51 $45 -6 +22.7% $36.68
2025-10-30 Goldman Sachs Scott Fidel $33 $38 +5 +1.8% $37.34
2025-10-14 Truist Financial — $102 $42 -60 +15.5% $36.35
2025-10-14 Morgan Stanley — $112 $38 -74 +5.4% $36.07
2025-10-14 Goldman Sachs — $74 $33 -41 -9.2% $36.36
2025-10-09 Mizuho Securities — $92 $40 -52 +4.0% $38.45
2025-10-07 Wells Fargo — $93 $41 -52 +8.9% $37.64
2025-09-05 Bernstein — Initiated $36 — +24.2% $28.98
2025-09-04 Barclays Andrew Mok $91 $33 -58 +9.8% $30.06
2025-07-15 Oppenheimer Michael Wiederhorn $95 $51 -44 +70.0% $30.00
2025-07-02 UBS — Initiated $45 — +33.2% $33.78
2025-04-15 Robert W. Baird Michael Ha Initiated $69 — +10.8% $62.28
2024-10-29 Barclays Andrew Mok $97 $91 -6 +47.6% $61.65

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+
Oct 27, 2026
DCF
5
ROE
3
ROA
3
D/E
1
P/E
3
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CNC receives an overall rating of B+. Strongest factors: DCF (5/5), P/B (4/5). Areas of concern: D/E (1/5).
Rating Change History
DateFromTo
2026-10-27 C+ B+
2026-05-12 B- C+
2026-04-30 C+ B-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 58 Grade B
Profitability
7
Balance Sheet
67
Earnings Quality
81
Growth
60
Value
57
Momentum
88
Safety
80
Cash Flow
58
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. CNC scores highest in Momentum (88/100) and lowest in Profitability (7/100). A grade of B indicates above-average fundamentals with room for improvement in select areas.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
3.18
Safe Zone
Piotroski F-Score
7/9
✓ ✓ ✓ ✓ ✓ ✓ ✗ ✗ ✓
Beneish M-Score
-17.45
Unlikely Manipulator
Ohlson O-Score
-7.97
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
BBB
Score: 55.8/100
Trend: Improving
Earnings Quality
100/100
OCF/NI: 3.25x
Accruals: -4.1%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. CNC scores 3.18, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CNC scores 7/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CNC's score of -17.45 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CNC's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CNC receives an estimated rating of BBB (score: 55.8/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). CNC's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
23.20x
PEG
0.21x
P/S
0.17x
P/B
1.53x
P/FCF
7.75x
P/OCF
6.47x
EV/EBITDA
5.99x
EV/Revenue
0.12x
EV/EBIT
8.87x
EV/FCF
5.72x
Earnings Yield
4.76%
FCF Yield
12.90%
Shareholder Yield
0.19%
Graham Number
$54.68
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 23.2x earnings, CNC commands a growth premium. Graham's intrinsic value formula yields $54.68 per share, 26% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.761
NI / EBT
×
Interest Burden
0.752
EBT / EBIT
×
EBIT Margin
0.013
EBIT / Rev
×
Asset Turnover
2.413
Rev / Assets
×
Equity Multiplier
3.739
Assets / Equity
=
ROE
6.8%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CNC's ROE of 6.8% is driven by financial leverage (equity multiplier: 3.74x). Note: high leverage means ROE is amplified by debt rather than operational performance.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$25.13
Price/Value
2.47x
Margin of Safety
-147.18%
Premium
147.18%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with CNC's realized 0.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. CNC trades at a 147% premium to its adjusted intrinsic value of $25.13, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 23.2x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$68.67
Median 1Y
$66.38
5th Pctile
$31.52
95th Pctile
$139.45
Ann. Volatility
42.7%
Analyst Target
$75.57
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Michael F. Neidorff
Chairman, President and Chief Executive Officer
$1,500,000 $12,829,500 $21,968,983
Cynthia J. Brinkley
Executive Vice President, Global Corporate Development
$650,000 $2,813,000 $4,681,485
Jesse N. Hunter
Executive Vice President, Products
$650,000 $1,969,100 $4,442,868
Jeffrey A. Schwaneke
Executive Vice President and Chief Financial Officer (effective March 1, 2016)
$632,671 $2,250,400 $4,325,029
Keith H. Williamson
Executive Vice President, Secretary and General Counsel
$600,000 $843,900 $3,049,469
William N. Scheffel
Former Executive Vice President and Chief Financial Officer (retired effective March 1, 2016)
$121,154 $— $889,807

CEO Pay Ratio

101:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $21,968,983
Avg Employee Cost (SGA/emp): $217,077
Employees: 61,100

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
61,100
+1.0% YoY
Revenue / Employee
$3,187,840
Rev: $194,777,000,000
Profit / Employee
$-109,214
NI: $-6,673,000,000
SGA / Employee
$217,077
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
ROE 5.1% 5.6% 7.1% 7.8% 4.7% 5.7% 10.4% 9.6% 10.8% 10.5% 10.6% 11.7% 12.7% 12.6% 7.5% -21.9% -28.8% -26.1% -20.4% 6.8% 6.77%
ROA 1.8% 2.0% 2.4% 2.5% 1.5% 1.8% 3.3% 3.0% 3.3% 3.3% 3.4% 3.7% 4.0% 4.1% 2.4% -6.4% -8.3% -7.7% -6.0% 1.8% 1.81%
ROIC 3.8% 4.0% 5.4% 5.7% 2.6% 3.0% 6.6% 8.0% 8.8% 8.3% 8.7% 8.0% 8.4% 9.5% 5.1% -23.4% -28.9% -41.0% -37.1% 6.4% 6.39%
ROCE 4.7% 5.0% 5.7% 6.6% 5.4% 5.8% 8.8% 9.1% 9.0% 8.8% 8.9% 9.6% 10.3% 10.5% 6.9% -10.0% -10.8% -13.9% -9.4% 6.4% 6.35%
Gross Margin 11.2% 11.7% 12.5% 11.1% 10.8% 11.8% 12.0% 12.0% 9.3% 11.5% 11.1% 9.6% 9.1% 11.2% 6.0% 16.4% 15.2% 21.9% 10.4% -0.6% -0.61%
Operating Margin 1.9% 3.4% -0.4% 1.3% -0.8% 3.1% 3.1% 1.9% -0.5% 2.7% 3.1% 1.6% 0.4% 3.3% -0.9% -14.0% -3.5% 3.7% 3.1% -0.6% -0.61%
Net Margin 1.8% 2.3% -0.5% 2.1% -0.6% 2.9% 2.8% 1.2% 0.1% 2.9% 2.9% 1.7% 0.7% 2.8% -0.5% -13.3% -2.2% 3.1% 2.5% -0.1% -0.14%
EBITDA Margin 3.8% 4.6% 0.8% 4.3% 1.7% 4.9% 5.1% 3.4% 1.3% 4.8% 5.0% 3.4% 2.0% 4.8% 0.5% -12.5% -2.1% 5.1% 4.4% 0.6% 0.64%
FCF Margin 2.6% 3.3% 4.3% 5.3% 3.6% 5.7% 5.2% 3.6% 4.7% 1.7% 1.4% 0.2% -0.3% 0.9% 0.6% 1.8% 2.2% 3.2% 4.6% 2.0% 2.03%
OCF Margin 3.3% 4.0% 5.1% 6.0% 4.3% 6.4% 5.8% 4.2% 5.2% 2.1% 1.9% 0.6% 0.1% 1.3% 1.0% 2.2% 2.6% 3.6% 5.0% 2.4% 2.44%
ROE 3Y Avg snapshot only -2.48%
ROE 5Y Avg snapshot only 2.03%
ROA 3Y Avg snapshot only -0.29%
ROIC 3Y Avg snapshot only -3.90%
ROIC Economic snapshot only 2.67%
Cash ROA snapshot only 5.98%
Cash ROIC snapshot only 33.47%
CROIC snapshot only 27.96%
NOPAT Margin snapshot only 0.46%
Pretax Margin snapshot only 0.99%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 5.25%
SBC / Revenue snapshot only 0.09%
Valuation
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
P/E Ratio 36.20 33.22 26.55 22.43 38.20 23.61 13.68 15.25 14.77 15.44 12.47 12.85 9.20 8.76 13.04 -3.31 -3.03 -2.52 -6.26 21.01 23.199
P/S Ratio 0.39 0.37 0.36 0.32 0.32 0.24 0.25 0.25 0.26 0.27 0.22 0.24 0.19 0.18 0.15 0.09 0.10 0.08 0.16 0.16 0.174
P/B Ratio 1.82 1.83 1.88 1.78 1.91 1.40 1.45 1.47 1.54 1.57 1.29 1.44 1.15 1.08 0.98 0.84 1.01 0.76 1.42 1.38 1.528
P/FCF 14.80 11.44 8.25 6.03 8.74 4.17 4.85 6.84 5.50 16.22 15.56 160.87 -62.06 20.27 24.81 5.22 4.68 2.56 3.56 7.75 7.752
P/OCF 11.60 9.36 7.07 5.31 7.33 3.73 4.33 5.96 4.95 12.69 11.90 41.14 197.47 14.27 15.49 4.31 3.97 2.26 3.27 6.47 6.475
EV/EBITDA 14.36 14.23 12.55 10.41 12.84 8.96 6.57 6.33 6.97 7.14 5.66 6.70 5.35 4.83 5.76 -5.48 -4.42 -1.99 -7.68 5.99 5.989
EV/Revenue 0.45 0.45 0.41 0.35 0.37 0.26 0.26 0.24 0.25 0.26 0.21 0.24 0.20 0.18 0.15 0.09 0.11 0.04 0.11 0.12 0.116
EV/EBIT 22.91 22.24 18.92 15.17 20.12 13.38 8.57 8.30 9.05 9.21 7.25 8.49 6.69 5.99 7.86 -3.82 -3.49 -1.55 -5.28 8.87 8.869
EV/FCF 17.23 13.68 9.42 6.61 10.05 4.61 5.11 6.60 5.39 15.58 14.42 161.01 -67.66 20.96 25.08 4.73 4.88 1.40 2.34 5.72 5.720
Earnings Yield 2.8% 3.0% 3.8% 4.5% 2.6% 4.2% 7.3% 6.6% 6.8% 6.5% 8.0% 7.8% 10.9% 11.4% 7.7% -30.2% -33.0% -39.7% -16.0% 4.8% 4.76%
FCF Yield 6.8% 8.7% 12.1% 16.6% 11.4% 24.0% 20.6% 14.6% 18.2% 6.2% 6.4% 0.6% -1.6% 4.9% 4.0% 19.2% 21.4% 39.1% 28.1% 12.9% 12.90%
PEG Ratio snapshot only 0.208
Price/Tangible Book snapshot only 4.188
EV/OCF snapshot only 4.778
EV/Gross Profit snapshot only 0.994
Acquirers Multiple snapshot only 19.057
Shareholder Yield snapshot only 0.19%
Graham Number snapshot only $54.68
Leverage & Solvency
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Current Ratio 1.11 1.05 1.11 1.06 1.06 1.07 1.11 1.12 1.11 1.17 1.17 1.10 1.11 1.11 1.10 1.08 1.68 1.12 1.15 1.16 1.164
Quick Ratio 1.11 1.05 1.11 1.06 1.06 1.07 1.11 1.12 1.11 1.17 1.17 1.10 1.11 1.11 1.10 1.08 1.68 1.12 1.15 1.16 1.164
Debt/Equity 0.85 0.83 0.85 0.85 0.89 0.86 0.83 0.76 0.73 0.67 0.64 0.64 0.74 0.66 0.64 0.84 0.94 0.76 0.71 0.70 0.700
Net Debt/Equity 0.30 0.36 0.27 0.17 0.29 0.15 0.08 -0.05 -0.03 -0.06 -0.09 0.00 0.10 0.04 0.01 -0.08 0.04 -0.34 -0.49 -0.36 -0.362
Debt/Assets 0.29 0.27 0.27 0.27 0.28 0.26 0.26 0.23 0.22 0.22 0.21 0.21 0.24 0.21 0.20 0.21 0.24 0.20 0.19 0.20 0.196
Debt/EBITDA 5.73 5.42 4.95 4.53 5.18 5.02 3.59 3.36 3.36 3.17 3.06 2.99 3.13 2.83 3.74 -6.07 -3.93 -3.68 -5.90 4.11 4.109
Net Debt/EBITDA 2.02 2.34 1.56 0.92 1.69 0.85 0.33 -0.23 -0.14 -0.29 -0.45 0.01 0.44 0.16 0.06 0.57 -0.19 1.66 4.01 -2.13 -2.127
Interest Coverage 3.73 4.08 4.56 5.00 3.95 4.22 6.48 6.05 5.96 6.09 6.27 6.52 7.06 7.53 5.01 -6.09 -8.92 -8.49 -6.07 4.03 4.028
Equity Multiplier 2.92 3.05 3.08 3.20 3.20 3.31 3.23 3.34 3.28 3.06 3.04 3.02 3.12 3.12 3.15 3.92 3.89 3.79 3.68 3.57 3.570
Cash Ratio snapshot only 0.604
Debt Service Coverage snapshot only 5.965
Cash to Debt snapshot only 1.518
FCF to Debt snapshot only 0.255
Defensive Interval snapshot only 741.8 days
Efficiency & Turnover
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Asset Turnover 1.71 1.74 1.81 1.78 1.86 1.76 1.80 1.81 1.91 1.88 1.90 1.94 1.95 2.00 2.10 2.26 2.43 2.36 2.29 2.41 2.413
Inventory Turnover — — — — — — — — — — — — — — — — — — — — —
Receivables Turnover 11.49 9.59 10.89 11.20 11.33 9.32 10.66 10.26 10.69 9.71 10.45 9.57 9.25 8.62 9.34 8.98 10.30 9.46 9.78 8.96 8.964
Payables Turnover 14.56 14.39 14.39 14.14 14.51 12.70 13.94 10.73 10.68 12.15 12.81 10.26 9.99 11.65 12.60 10.98 10.19 10.95 10.32 10.63 10.632
DSO 32 38 34 33 32 39 34 36 34 38 35 38 39 42 39 41 35 39 37 41 40.7 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 25 25 25 26 25 29 26 34 34 30 28 36 37 31 29 33 36 33 35 34 34.3 days
Cash Conversion Cycle 7 13 8 7 7 10 8 2 -0 8 6 3 3 11 10 7 -0 5 2 6 6.4 days
Fixed Asset Turnover snapshot only 92.314
Cash Velocity snapshot only 8.255
Capital Intensity snapshot only 0.407
Growth (YoY)
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Revenue 13.4% 15.7% 16.6% 16.3% 14.7% 9.8% 7.1% 6.0% 6.5% 6.3% 6.6% 7.7% 5.9% 8.9% 13.0% 14.9% 19.4% 17.0% 8.7% 4.8% 4.75%
Net Income -25.5% -39.2% 1.6% 1.7% -10.8% -0.9% 45.9% 21.4% 1.2% 84.4% 4.1% 25.5% 22.3% 26.3% -27.2% -2.7% -3.0% -2.9% -3.5% 1.3% 1.28%
EPS -27.0% -39.3% 1.6% 1.8% -5.7% 5.6% 54.7% 30.2% 1.3% 89.8% 7.9% 29.7% 31.0% 36.4% -21.8% -2.8% -3.1% -2.9% -3.5% 1.3% 1.27%
FCF -28.9% -11.4% 1.1% 32.8% 59.5% 93.0% 27.8% -27.3% 38.0% -69.0% -70.4% -95.5% -1.1% -42.7% -52.2% 12.7% 9.8% 3.3% 7.3% 18.0% 18.00%
EBITDA -16.9% -25.8% 42.6% 50.3% 4.1% 3.2% 32.4% 19.4% 36.4% 31.6% -3.2% 3.6% 10.4% 14.0% -18.3% -1.5% -1.8% -1.7% -1.6% 2.3% 2.31%
Op. Income -42.1% -49.8% 50.3% 84.2% -26.1% -35.3% 13.7% 29.0% 1.2% 1.2% 11.3% -1.3% 8.4% 27.9% -33.4% -3.0% -3.4% -3.0% -3.8% 1.2% 1.21%
OCF Growth snapshot only 16.66%
Asset Growth snapshot only -3.42%
Equity Growth snapshot only 6.01%
Debt Growth snapshot only -11.61%
Shares Change snapshot only 0.61%
Growth (CAGR)
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Revenue 3Y 28.0% 26.8% 25.7% 25.1% 24.6% 21.2% 17.3% 13.9% 11.5% 10.6% 10.0% 9.9% 9.0% 8.3% 8.9% 9.5% 10.5% 10.6% 9.4% 9.1% 9.06%
Revenue 5Y 25.4% 24.0% 24.4% 24.4% 24.5% 24.0% 23.2% 21.6% 20.7% 18.9% 17.8% 17.5% 16.9% 15.5% 14.2% 12.8% 11.9% 11.5% 10.4% 9.9% 9.85%
EPS 3Y 2.1% -0.6% 1.6% 2.5% -11.8% 20.5% 23.0% 9.4% 17.3% 6.8% 62.7% 67.5% 42.5% 39.8% 9.3% — — — — -13.2% -13.16%
EPS 5Y 7.1% 4.3% 6.9% 7.3% -1.7% -1.5% 12.8% 16.3% 18.6% 14.5% 11.8% 12.7% 16.0% 35.3% 9.5% — — — — 18.9% 18.87%
Net Income 3Y 14.4% 11.4% 13.4% 14.2% -3.1% 20.6% 20.4% 6.4% 14.3% 3.6% 57.7% 60.9% 34.9% 32.1% 3.4% — — — — -15.8% -15.76%
Net Income 5Y 18.9% 15.7% 18.2% 18.5% 7.7% 7.6% 20.3% 22.4% 24.6% 20.4% 17.2% 17.8% 20.1% 32.5% 5.7% — — — — 14.7% 14.70%
EBITDA 3Y 21.5% 19.3% 18.3% 18.1% 13.2% 20.0% 13.8% 5.4% 5.7% 0.3% 22.3% 23.0% 16.2% 15.7% 1.5% — — — — -12.7% -12.70%
EBITDA 5Y 19.1% 16.5% 17.2% 18.2% 18.7% 15.8% 22.4% 24.0% 20.5% 18.2% 16.2% 15.3% 16.9% 21.0% 3.1% — — — — 3.6% 3.62%
Gross Profit 3Y 19.0% 19.7% 21.3% 22.5% 23.5% 20.5% 11.5% 7.8% 4.4% 3.5% 7.0% 6.5% 5.8% 5.2% -0.5% 6.8% 12.7% 20.6% 22.7% 9.2% 9.21%
Gross Profit 5Y 20.7% 19.7% 21.3% 22.0% 23.5% 21.0% 19.6% 17.8% 15.5% 14.8% 13.8% 13.4% 13.7% 12.5% 5.4% 7.4% 9.4% 13.5% 17.2% 10.4% 10.45%
Op. Income 3Y 7.0% 7.3% 8.9% 5.2% -9.5% -0.0% -1.0% -5.3% -1.7% -10.6% 23.9% 32.9% 21.2% 22.0% -5.5% — — — — -25.2% -25.22%
Op. Income 5Y 7.2% 6.0% 8.1% 7.4% 1.9% -3.1% 10.8% 17.8% 15.0% 11.9% 10.4% 8.2% 12.3% 22.9% -6.3% — — — — -0.1% -0.12%
FCF 3Y 80.6% 2.9% 58.7% 1.1% 91.1% — 58.6% 75.5% 16.1% -19.0% -7.6% -64.9% — -30.0% -43.5% -23.5% -6.3% -8.9% 5.4% -10.1% -10.10%
FCF 5Y 16.4% 11.2% 17.9% 27.3% 37.6% 40.6% 43.3% 26.1% 67.0% 1.1% 8.6% -20.8% — — -10.9% 27.2% -1.4% 5.3% 25.7% -6.8% -6.84%
OCF 3Y 50.5% 96.2% 48.2% 78.4% 61.6% — 46.5% 49.6% 13.5% -16.8% -7.7% -47.2% -66.8% -26.4% -37.2% -21.8% -6.7% -8.5% 4.4% -8.8% -8.85%
OCF 5Y 17.8% 12.8% 18.3% 26.4% 33.3% 35.1% 35.6% 22.0% 45.5% 36.4% 6.6% -8.6% -36.4% — -8.7% 16.8% -1.6% 4.4% 21.1% -6.1% -6.15%
Assets 3Y 36.4% 35.2% 33.1% 33.3% 23.3% 7.7% 6.6% 7.3% 7.2% 5.5% 5.1% 1.9% 1.7% 1.6% 2.1% 0.4% 0.3% -0.7% 0.1% -2.1% -2.06%
Assets 5Y 31.2% 31.2% 30.0% 29.8% 28.6% 26.9% 23.6% 22.1% 22.3% 19.7% 19.3% 19.2% 15.0% 5.6% 4.8% 3.7% 2.5% 2.9% 3.0% 0.4% 0.39%
Equity 3Y 34.9% 33.0% 29.3% 27.3% 24.2% 2.1% 0.8% -0.6% 0.1% 0.8% 1.8% 1.0% -0.5% 0.9% 1.4% -6.2% -6.0% -5.1% -4.2% -4.2% -4.25%
Book Value 3Y 20.3% 18.7% 15.9% 14.2% 13.1% 2.0% 3.0% 2.2% 2.7% 3.9% 5.0% 5.2% 5.1% 6.8% 7.2% -0.8% -1.8% -1.5% -0.9% -1.3% -1.30%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Revenue Stability 0.93 0.95 0.97 0.98 0.97 0.98 0.99 0.98 0.97 0.96 0.96 0.96 0.95 0.95 0.97 0.98 0.96 0.97 0.99 0.99 0.987
Earnings Stability 0.75 0.44 0.30 0.30 0.31 0.22 0.49 0.43 0.47 0.43 0.64 0.53 0.59 0.59 0.44 0.25 0.26 0.30 0.25 0.10 0.095
Margin Stability 0.90 0.91 0.94 0.92 0.92 0.91 0.93 0.90 0.89 0.90 0.94 0.94 0.95 0.95 0.86 0.89 0.89 0.84 0.78 0.95 0.947
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.50 0.50 0.00 0.00 1.00 1.00 0.50 0.50 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.50 0.500
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 0 1 1 1 1
Earnings Persistence 0.90 0.84 0.50 0.50 0.96 1.00 0.82 0.91 0.50 0.50 0.98 0.90 0.91 0.89 0.89 0.20 0.20 0.20 0.20 0.20 0.200
Earnings Smoothness 0.71 0.51 0.12 0.07 0.89 0.99 0.63 0.81 0.23 0.41 0.96 0.77 0.80 0.77 0.68 — — — — — —
ROE Trend -0.04 -0.01 0.03 0.03 -0.01 -0.02 0.06 0.04 0.05 0.04 0.01 0.02 0.05 0.04 -0.03 -0.36 -0.45 -0.41 -0.32 0.14 0.136
Gross Margin Trend -0.02 -0.01 -0.01 -0.01 -0.01 -0.01 -0.00 0.00 -0.00 -0.00 -0.01 -0.01 -0.01 -0.01 -0.02 -0.00 0.01 0.04 0.06 0.01 0.011
FCF Margin Trend 0.00 0.02 0.02 0.02 0.00 0.02 0.02 -0.01 0.02 -0.03 -0.03 -0.04 -0.04 -0.03 -0.03 -0.00 0.00 0.02 0.04 0.01 0.011
Sustainable Growth Rate 5.1% 5.6% 7.1% 7.8% 4.7% 5.7% 10.4% 9.6% 10.8% 10.5% 10.6% 11.7% 12.7% 12.6% 7.5% — — — — 6.8% 6.77%
Internal Growth Rate 1.9% 2.0% 2.5% 2.6% 1.6% 1.8% 3.4% 3.0% 3.5% 3.4% 3.5% 3.8% 4.1% 4.2% 2.5% — — — — 1.8% 1.84%
Cash Flow Quality
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
OCF/Net Income 3.12 3.55 3.75 4.23 5.21 6.32 3.16 2.56 2.98 1.22 1.05 0.31 0.05 0.61 0.84 -0.77 -0.76 -1.11 -1.92 3.25 3.245
FCF/OCF 0.78 0.82 0.86 0.88 0.84 0.89 0.89 0.87 0.90 0.78 0.76 0.26 -3.18 0.70 0.62 0.83 0.85 0.88 0.92 0.84 0.835
FCF/Net Income snapshot only 2.710
OCF/EBITDA snapshot only 1.254
CapEx/Revenue 0.7% 0.7% 0.7% 0.7% 0.7% 0.7% 0.6% 0.5% 0.5% 0.5% 0.4% 0.4% 0.4% 0.4% 0.4% 0.4% 0.4% 0.4% 0.4% 0.4% 0.40%
CapEx/Depreciation snapshot only 0.636
Accruals Ratio -0.04 -0.05 -0.07 -0.08 -0.07 -0.10 -0.07 -0.05 -0.07 -0.01 -0.00 0.03 0.04 0.02 0.00 -0.11 -0.15 -0.16 -0.18 -0.04 -0.041
Sloan Accruals snapshot only 0.021
Cash Flow Adequacy snapshot only 6.070
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% — — — — 0.0% 0.00%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% — 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 22.0% 22.6% 36.8% 94.9% 2.6% 2.3% 1.3% 1.2% 60.4% 49.8% 62.3% 72.1% 94.5% 87.3% 1.3% — — — — 4.0% 4.04%
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.6% 0.7% 1.4% 4.2% 6.7% 9.8% 9.4% 8.1% 4.1% 3.2% 5.0% 5.6% 10.3% 10.0% 9.9% 8.1% 2.4% 2.9% 0.1% 0.2% 0.19%
Net Buyback Yield 0.6% 0.7% 1.4% 4.2% 6.6% 9.6% 9.2% 7.9% 4.0% 3.1% 4.9% 5.5% 10.1% 9.8% 9.7% 7.9% 2.2% 2.6% -0.0% 0.1% 0.08%
Total Shareholder Return 0.6% 0.7% 1.4% 4.2% 6.6% 9.6% 9.2% 7.9% 4.0% 3.1% 4.9% 5.5% 10.1% 9.8% 9.7% 7.9% 2.2% 2.6% -0.0% 0.1% 0.08%
DuPont Factors
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Tax Burden (NI/EBT) 0.74 0.74 0.80 0.77 0.61 0.67 0.70 0.68 0.75 0.74 0.75 0.78 0.78 0.76 0.75 1.09 0.99 1.01 1.10 0.76 0.761
Interest Burden (EBT/EBIT) 0.73 0.76 0.78 0.80 0.75 0.76 0.85 0.83 0.83 0.84 0.84 0.85 0.86 0.87 0.80 1.16 1.11 1.12 1.16 0.75 0.752
EBIT Margin 0.02 0.02 0.02 0.02 0.02 0.02 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.02 -0.02 -0.03 -0.03 -0.02 0.01 0.013
Asset Turnover 1.71 1.74 1.81 1.78 1.86 1.76 1.80 1.81 1.91 1.88 1.90 1.94 1.95 2.00 2.10 2.26 2.43 2.36 2.29 2.41 2.413
Equity Multiplier 2.80 2.86 2.92 3.07 3.05 3.18 3.15 3.27 3.24 3.18 3.13 3.17 3.20 3.09 3.10 3.41 3.45 3.41 3.39 3.74 3.739
Per Share
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
EPS (Diluted TTM) $2.28 $2.53 $3.19 $3.47 $2.15 $2.68 $4.93 $4.52 $5.03 $5.08 $5.32 $5.86 $6.58 $6.93 $4.16 $-10.77 $-13.59 $-13.00 $-10.25 $2.96 $2.96
Book Value/Share $45.28 $46.00 $45.04 $43.71 $42.96 $45.21 $46.65 $46.73 $48.06 $50.10 $51.53 $52.16 $52.61 $56.04 $55.53 $42.65 $40.63 $43.24 $45.34 $44.94 $45.14
Tangible Book/Share $-1.35 $-3.17 $-2.90 $-3.76 $-2.98 $-0.95 $0.79 $2.70 $4.06 $6.45 $7.61 $7.96 $6.86 $10.28 $9.80 $10.74 $9.34 $12.57 $15.12 $14.83 $14.83
Revenue/Share $212.89 $225.48 $236.61 $243.80 $258.15 $264.06 $268.80 $277.31 $286.45 $289.03 $297.21 $308.91 $324.86 $339.80 $361.04 $378.42 $396.64 $399.73 $389.31 $394.00 $394.00
FCF/Share $5.57 $7.36 $10.25 $12.91 $9.39 $15.15 $13.90 $10.07 $13.49 $4.84 $4.26 $0.47 $-0.98 $2.99 $2.19 $6.83 $8.80 $12.80 $18.02 $8.01 $8.01
OCF/Share $7.11 $9.00 $11.96 $14.66 $11.18 $16.93 $15.57 $11.57 $14.98 $6.19 $5.57 $1.83 $0.31 $4.26 $3.51 $8.27 $10.36 $14.48 $19.62 $9.59 $9.59
Cash/Share $24.77 $21.85 $26.09 $29.59 $25.71 $32.48 $35.22 $37.75 $36.55 $36.55 $38.09 $33.56 $33.24 $34.70 $35.01 $39.17 $36.43 $47.90 $54.37 $47.73 $47.73
EBITDA/Share $6.68 $7.08 $7.70 $8.20 $7.35 $7.79 $10.80 $10.50 $10.45 $10.55 $10.84 $11.25 $12.35 $12.99 $9.53 $-5.90 $-9.72 $-8.96 $-5.49 $7.65 $7.65
Debt/Share $38.29 $38.38 $38.08 $37.14 $38.10 $39.07 $38.80 $35.30 $35.11 $33.45 $33.21 $33.63 $38.70 $36.77 $35.61 $35.80 $38.24 $33.03 $32.36 $31.45 $31.45
Net Debt/Share $13.53 $16.53 $11.99 $7.55 $12.39 $6.60 $3.58 $-2.45 $-1.44 $-3.10 $-4.87 $0.07 $5.47 $2.07 $0.60 $-3.37 $1.81 $-14.87 $-22.01 $-16.28 $-16.28
Academic Models
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 3.180
Altman Z-Prime snapshot only 1.773
Piotroski F-Score 5 4 7 7 6 8 7 9 8 8 8 6 5 6 5 5 6 7 6 7 7
Beneish M-Score -2.37 -2.34 -2.65 -2.68 -2.71 -3.00 -2.84 -2.65 -2.55 -2.42 -2.24 -2.03 -2.03 -2.09 -1.73 -3.05 -3.44 -3.72 -3.80 -17.45 -17.448
Ohlson O-Score snapshot only -7.968
ROIC (Greenblatt) snapshot only 30.04%
Net-Net WC snapshot only $-23.30
EVA snapshot only $-511848093.60
Credit
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Credit Rating snapshot only BBB
Credit Score 48.84 48.01 56.17 66.13 56.42 54.59 66.62 63.01 67.41 59.92 61.38 61.21 57.11 61.89 56.97 41.36 50.33 50.55 52.54 55.80 55.798
Credit Grade snapshot only 9
Credit Trend snapshot only 14.439
Implied Spread (bps) snapshot only 275.000
Industry Credit Rank snapshot only 33
Sector Credit Rank snapshot only 40

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms